Director
The IPO Chair, led by its director, Prof. Aleix Prat, was established with the aim of revolutionizing the application of precision medicine in the field of oncology. To achieve this goal, innovation, excellence, knowledge and collaboration in teaching and research will be promoted, with the aim of transforming the treatment of cancer and improving the lives of patients.
Dr. Aleix Prat is a physician, researcher, educator and entrepreneur, internationally recognized for his contributions to precision oncology, especially in breast cancer. He completed a medical oncology fellowship at Hospital Vall d'Hebron (2004-2008) under the supervision of Dr. Josep Baselga and continued his education in the United States (2008-2012). From 2014 to 2022, he led the Medical Oncology Department of Hospital Clínic de Barcelona, and since 2023 he has been the director of the Institute of Cancer and Blood Diseases of the same centre. Since 2024, he also leads the Clinic Barcelona Comprehensive Cancer Centre.
Dr. Prat is a senior lecturer in the Department of Medicine at the University of Barcelona and has a translational research laboratory at the Hospital Clínic, where he has led the development of innovative diagnostic tests such as HER2DX and TNBC-DX. He has published more than 300 articles in high-impact scientific journals, has led numerous clinical trials, and is a regular guest speaker at major conferences around the world.
With his 360° view of the oncology field, ranging from basic and translational research to clinical application and the development of new technologies, Dr. Prat works tirelessly to improve the treatment and prognosis of cancer patients.
Dr. Prat is a senior lecturer in the Department of Medicine at the University of Barcelona and has a translational research laboratory at the Hospital Clínic, where he has led the development of innovative diagnostic tests such as HER2DX and TNBC-DX. He has published more than 300 articles in high-impact scientific journals, has led numerous clinical trials, and is a regular guest speaker at major conferences around the world.
With his 360° view of the oncology field, ranging from basic and translational research to clinical application and the development of new technologies, Dr. Prat works tirelessly to improve the treatment and prognosis of cancer patients.
News
